Anokion SA is a Swiss biotechnology company that aims to make a meaningful difference in the lives of patients suffering from autoimmune diseases by restoring normal immune tolerance. The company is focused on both prevalent and rare autoimmune diseases, including celiac disease, multiple sclerosis and type 1 diabetes. Anokion’s distinct approach leverages the company’s immune-based platform, which targets natural pathways in the liver to restore immune tolerance and address the underlying cause of autoimmune disease.
View Top Employees from AnokionWebsite | http://www.anokion.com |
Revenue | $10 million |
Funding | $40 million |
Employees | 43 (43 on RocketReach) |
Founded | 2010 |
Address | 50 Hampshire St, Cambridge, Massachusetts 02139, US |
Phone | +41 21 693 72 37 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Category | Biotechnology Research, Pharmaceuticals, Biotechnology, Immunoengineering, Healthcare, Science and Engineering, Protein engineering, Clinical Trials, Biologics, Health Care, Autoimmune diseases, Therapeutics |
Web Rank | 19 Million |
Keywords | immune tolerance |
Competitors | Altus Technologies Corporation, Complix N.V., Five Prime Therapeutics, Inc., Step Pharma, Synthorx Inc |
SIC | 87, 873 |
NAICS | 621, 62151, 541, 54, 541714, 5417, 54171, 6215, 62 |
Looking for a particular Anokion employee's phone or email?
The Anokion annual revenue was $10 million in 2023.
Angela Card is the Vice President, Product Development of Anokion.
43 people are employed at Anokion.
Anokion is based in Cambridge, Massachusetts.
The NAICS codes for Anokion are [621, 62151, 541, 54, 541714, 5417, 54171, 6215, 62].
The SIC codes for Anokion are [87, 873].